Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MCF7 | Ulixertinib | 0.01 | 0.9259 | 0.00453 |
| MCF7 | Ulixertinib | 0.031622777 | 0.9175 | 0.00146 |
| MCF7 | Ulixertinib | 0.031622777 | 0.8924 | 0.00261 |
| MCF7 | Ulixertinib | 0.031622777 | 0.7533 | 0.00906 |
| MCF7 | Ulixertinib | 0.1 | 0.9060 | -0.00164 |
| MCF7 | Ulixertinib | 0.1 | 0.8389 | 0.02333 |
| MCF7 | Ulixertinib | 0.1 | 1.0147 | 0.00015 |
| MCF7 | Ulixertinib | 0.316227766 | 0.5621 | 0.00643 |
| MCF7 | Ulixertinib | 0.316227766 | 0.8016 | -0.00077 |
| MCF7 | Ulixertinib | 0.316227766 | 0.7838 | 0.00034 |
| MCF7 | Ulixertinib | 1.0 | 0.5854 | 0.00264 |
| MCF7 | Ulixertinib | 1.0 | 0.7609 | 0.00535 |
| MCF7 | Ulixertinib | 1.0 | 0.7580 | 0.00341 |
| MCF7 | Ulixertinib | 3.16227766 | 0.5917 | 0.00171 |
| MCF7 | Ulixertinib | 3.16227766 | 0.4807 | 0.01124 |
| MCF7 | Ulixertinib | 3.16227766 | 0.5992 | 0.00532 |
| MCF7 | Ulixertinib | 10.0 | 0.2423 | 0.01479 |
| MCF7 | Ulixertinib | 10.0 | 0.3222 | 0.01435 |
| MCF7 | Ulixertinib | 10.0 | 0.4439 | 0.00890 |
| MCF7 | Alvocidib | 0.0001 | 1.1108 | 0.00155 |
| MCF7 | Alvocidib | 0.0001 | 1.0415 | -0.00238 |
| MCF7 | Alvocidib | 0.0001 | 1.1211 | -0.00267 |
| MCF7 | Alvocidib | 0.000316228 | 0.9175 | -0.00120 |
| MCF7 | Alvocidib | 0.000316228 | 0.8366 | 0.00209 |
| MCF7 | Alvocidib | 0.000316228 | 1.0805 | 0.00439 |